Refine your search
25 trials found for Lung cancer, Lung Neoplasm, Lung Carcinoma
Recruiting
Not yet recruiting
Recruiting
NCT06487078
Analysis of the Effectiveness and Safety of Lorlatinib in Untreated ALK-Positive NSCLC Patients in a French Real-World Context
ALK+ Non-Small-Cell Lung Carcinoma
Male or Female
18+ years
1study location(s)
Recruiting
NCT04557449
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
Liposarcoma, Prostate Cancer, Breast Neoplasms, Adenocarcinoma of Lung
Male or Female
18+ years
38study location(s)
Recruiting
NCT05599412
Post Marketing Surveillance(PMS) Study of Lorviqua in Korea
Metastatic ALK+ Non Small Cell Lung Cancer
Male or Female
18+ years
1study location(s)
Jul 10, 2025 - Planned start date (Not yet recruiting)
NCT07013474
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
COVID-19 Infection
Male or Female
18+ years
12study location(s)
Jun 30, 2025 - Planned start date (Not yet recruiting)
NCT06678555
A Study to Learn About Lorlatinib in Patients With Non-Small Cell Lung Cancer (NSCLC) Which Has Spread Out.
Carcinoma, Non-Small-Cell Lung
Male or Female
18+ years
Saved trials
Saved trials
You currently don’t have any saved trials. To save a trial, select the bookmark icon on the result listing.
Recruiting
Not yet recruiting
Contact us
For more information about participation in a Pfizer clinical trial, please email or call the Pfizer Clinical Trial Contact Center at 1-800-887-7002.